![Current Oncology | Free Full-Text | Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton’s Tyrosine Kinase Inhibitor in Canada Current Oncology | Free Full-Text | Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton’s Tyrosine Kinase Inhibitor in Canada](https://pub.mdpi-res.com/curroncol/curroncol-29-00164/article_deploy/html/images/curroncol-29-00164-g002.png?1647567798)
Current Oncology | Free Full-Text | Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton’s Tyrosine Kinase Inhibitor in Canada
![Secretary-General's remarks at the UN Biodiversity Conference — COP15 | United Nations Secretary-General Secretary-General's remarks at the UN Biodiversity Conference — COP15 | United Nations Secretary-General](https://www.un.org/sg/sites/www.un.org.sg/files/06-12-2022-COP15-Guterres-podium-02.jpg)